Abstract
The menace of multidrug resistance among bacterial infections is an issue of global public health. Treatment of these superbugs with first line antibiotics is associated with significant treatment failure leading to increased mortality and morbidity. Carbapenems and polymyxins are the saviour antibiotics in case of such infections. But the problem is compounded when these antimicrobials also fail. The addition of beta-lactamase inhibitor like sulbactam and disodium ethylenediaminetetraacetic acid broaden the in vitro antibacterial action of ceftriaxone. This novel combination has been found to be effective in most of the drug resistant bacterial strains.
Publisher
Journal of Pure and Applied Microbiology
Subject
Applied Microbiology and Biotechnology,Microbiology,Biotechnology
Reference30 articles.
1. 1. Chaudhary M, Mir MA, Ayub SG, Protocol 06 Group1. Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study. Braz J Infect Dis. 2017;21(4):408-417. doi: 10.1016/j.bjid.2017.02.007
2. 2. WHO. Antimicrobial resistance: global report on surveillance2014. WHO; 2016. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en/ [accessed March 17, 2020].
3. 3. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res. 2006;124(1):95-98.
4. 4. Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant Gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc. 2011;86(3):250-259. doi: 10.4065/mcp.2010.0674
5. 5. Fatima N, Shameem M, Khan HM, Shukla I. Determination of susceptibility breakpoints of a novel Antibiotic Adjuvant Entity CSE1034 in extended spectrum beta lactamases and metallo beta-lactamases producing resistant Enterobacteriaceae. J Microbiol Antimicrob. 2017;3(1):25-33.